Psyched Wellness (CSE:PSYC, OTCQB:PSYCF) Ltd has announced that its proprietary Amanita Muscaria Extract (AME-1) is now available for preorder in the USA.
The company offers consumers a unique opportunity to purchase a safe and legal extract of the mushroom that has been used for thousands of years by various groups around the world for its healing properties.
Psyched Wellness has approval to sell in the United States via Self-GRAS (Generally Regarded as Safe) designation, which allows the company to sell its AME-1 products. The company plans to submit the application for AME-1 as an NDI (a New Dietary Ingredient) to the FDA this fall. The product, called Calm, facilitates rest within the body and mind, and does not require a prescription. This leaves the retail landscape open to many possibilities for distribution and listing potential.
In a statement, Psyched Wellness chief commercial officer, Matthew Singh, commented: "Our entire team is excited to take this step into full-scale commercialization. We begin with the launch of Calm, then follow with additional skus and product innovation. Our presale initiative will build a sales pipeline and [hopefully] attract the attention of all individuals with an interest in this sector."
READ: Psyched Wellness gearing up for launch of Amanita Muscaria-derived product Calm in the US later this year
Singh added: "We firmly believe our product offerings will separate us from the pack when compared to any other mushroom company on the market today. Try Calm, the very first legal Amanita Muscaria product for sale in the United States, and discover what separates Psyched Wellness from all other companies working within our discipline."
To preorder Calm, interested parties can visit: shop.psyched-wellness.com.
Psyched Wellness is focused on the production and distribution of health and wellness products derived from the Amanita Muscaria mushroom.
The company has not been evaluated by the United States Food and Drug Administration or any other similar body of another jurisdiction and its products are not a substitute for professional medical care.
Contact the author at jon.hopkins@proactiveinvestors.com